Abstract
Quality of Life (QoL) in Patients With Relapsed/Refractory Non-Hodgkin Lymphoma (NHL) Treated with Polatuzumab Vedotin Plus Rituximab in the ROMULUS Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have